Belgian pharmaceutical company UCB is dropping its development of minzasolmin in patients with Parkinson's' disease after the ORCHESTRA study failed to meet its primary and secondary endpoints.

Throughout the 1990s and early 2000s, UCB transformed from a hybrid pharma/chemical firm into a pure-play biopharmaceutical company by shedding its packaging, film, and chemical businesses.

Throughout the 1990s and early 2000s, UCB transformed from a hybrid pharma/chemical firm into a pure-play biopharmaceutical company by shedding its packaging, film, and chemical businesses.

Based in Greenville, United Community Banks (UCB) is in the Finance sector, and so far this year, shares have seen a price change of 6.99%. The bank holding company is paying out a dividend of $0. ...

In a report released today, Charles Pitman CFA from Barclays reiterated a Buy rating on UCB SA (0NZT – Research Report), with a price target of ...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see United Community Banks, Inc. (NYSE:UCB) is about to trade ex-dividend in the next 4 days. The ...

UCB’s Bimzelx is firmly on physicians’ radars ... The market intelligence company found half of the physicians had trialed Bimzelx in PsA. Spherix compared the level of activity favorably ...

In a report released today, Catherine Mealor from KBW maintained a Hold rating on United Community Banks (UCB – Research Report), with a price target of $36.00. The company’s shares closed ...

United Commercial Bank PLC (UCB) signed an agreement with Dhaka Mass Transit Company Limited (DMTCL) to install CRM and ATM ...